☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Tacrolimus caution urged

The manufacturer of Tacrolimus (Prograf® and Advagraf®) has written to healthcare professionals to highlight the potential for medication errors with these two products.

Prograf is an immediate release formulation of tacrolimus that must be taken twice daily. Advagraf is a prolonged release formulation of tacrolimus that must be taken once daily.

These products are not interchangeable without careful supervision and monitoring. Changes have been agreed with regulatory agencies that will improve the product packaging and leaflets to highlight the differences.

Medication errors have caused serious adverse reactions including acute rejection of transplanted organs and toxicity due to elevated therapeutic levels.

Action: Clinicians should be aware of the potential for medication errors and take particular care when prescribing or dispensing this medication.

Share 'Tacrolimus caution urged' by emailShare 'Tacrolimus caution urged' on FacebookShare 'Tacrolimus caution urged' on TwitterShare 'Tacrolimus caution urged' on LinkedInShare 'Tacrolimus caution urged' on reddit


No Comments to “Tacrolimus caution urged”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.